- Home
- ALXO vs GCTS Comparison
ALXO vs GCTS Comparison
Compare ALXO & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- GCTS
- Stock Information
- Founded
- ALXO 2015
- GCTS 1998
- Country
- ALXO United States
- GCTS United States
- Employees
- ALXO N/A
- GCTS N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- GCTS Blank Checks
- Sector
- ALXO Health Care
- GCTS Finance
- Exchange
- ALXO Nasdaq
- GCTS Nasdaq
- Market Cap
- ALXO 76.5M
- GCTS 91.7M
- IPO Year
- ALXO 2020
- GCTS N/A
- Fundamental
- Price
- ALXO $0.66
- GCTS $1.78
- Analyst Decision
- ALXO Strong Buy
- GCTS Strong Buy
- Analyst Count
- ALXO 6
- GCTS 1
- Target Price
- ALXO $4.14
- GCTS $5.00
- AVG Volume (30 Days)
- ALXO 1.4M
- GCTS 132.9K
- Earning Date
- ALXO 03-06-2025
- GCTS 03-25-2025
- Dividend Yield
- ALXO N/A
- GCTS N/A
- EPS Growth
- ALXO N/A
- GCTS N/A
- EPS
- ALXO N/A
- GCTS N/A
- Revenue
- ALXO N/A
- GCTS $9,128,000.00
- Revenue This Year
- ALXO N/A
- GCTS N/A
- Revenue Next Year
- ALXO N/A
- GCTS $463.17
- P/E Ratio
- ALXO N/A
- GCTS N/A
- Revenue Growth
- ALXO N/A
- GCTS N/A
- 52 Week Low
- ALXO $0.65
- GCTS $1.55
- 52 Week High
- ALXO $17.83
- GCTS $30.52
- Technical
- Relative Strength Index (RSI)
- ALXO 33.23
- GCTS 40.62
- Support Level
- ALXO $0.65
- GCTS $1.79
- Resistance Level
- ALXO $0.74
- GCTS $2.14
- Average True Range (ATR)
- ALXO 0.07
- GCTS 0.12
- MACD
- ALXO -0.00
- GCTS -0.01
- Stochastic Oscillator
- ALXO 0.54
- GCTS 38.98
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.